Understanding prostate cancer differences in African American men
Protein kinase C signaling in prostate cancer health disparities
This research explores how a protein called PKCa might contribute to why prostate cancer is often more aggressive in African American men.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Miami School of Medicine NIH-funded |
| Lab location | 1 site (Coral Gables, United States) |
| Project ID | NIH-11187260 on NIH RePORTER |
What this research studies
Prostate cancer affects African American men more severely, with higher rates of diagnosis, faster progression, and increased mortality compared to men of European descent. This project aims to understand the biological reasons behind these differences, focusing on a specific protein called PKCa. We've found that PKCa is often overactive in aggressive prostate cancer and plays a role in how cancer cells invade and grow. By studying this protein, we hope to uncover new ways to address these health disparities.
Who could benefit from this research
Good fit: This research is focused on understanding prostate cancer as it affects African American men.
Not a fit: Patients without prostate cancer or those not of African American descent may not directly benefit from this specific line of inquiry.
Why it matters
Potential benefit: If successful, this work could lead to new ways to detect, treat, or prevent aggressive prostate cancer, especially for African American men.
How similar studies have performed: While the role of PKCa in general cancer is known, its specific contribution to racial disparities in prostate cancer is a novel area of focus for this project.
Where this research is happening
Coral Gables, United States
- University of Miami School of Medicine — Coral Gables, United States (Active)
Researchers
- Principal investigator: Kazanietz, Marcelo G. — University of Miami School of Medicine
- Study coordinator: Kazanietz, Marcelo G.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.